Coexistence and management of abdominal aortic aneurysm and coronary artery disease by Hołda, Mateusz K. et al.
Address for correspondence: Mateusz K. Hołda, MD, PhD, HEART — Heart Embryology and Anatomy Research Team,  
Department of Anatomy, Jagiellonian University Medical College, ul. Kopernika 12, 31–034 Kraków, Poland,  
tel/fax: +48 12 422 95 11, e-mail: mkh@onet.eu
Received: 25.06.2018 Accepted: 23.07.2018
Coexistence and management of abdominal aortic 
aneurysm and coronary artery disease 
Mateusz K. Hołda1, 2, Paweł Iwaszczuk1, Karolina Wszołek1, Jakub Chmiel1,  
Andrzej Brzychczy3, Mariusz Trystuła3, Marcin Misztal3 
1Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, Krakow, Poland 
3HEART — Heart Embryology and Anatomy Research Team, Department of Anatomy,  
Jagiellonian University Medical College, Krakow, Poland 
3Department of Vascular Surgery and Endovascular Procedures, John Paul II Hospital, Krakow, Poland
Abstract
Background: Abdominal aortic aneurysm (AAA) and coronary atherosclerosis share common risk 
factors. In this study,  a single-center management experience of patients with a coexistence of AAA and 
coronary artery disease (CAD) is presented. 
Methods: 271 consecutive patients who underwent elective AAA repair were reviewed. Coronary imag-
ing in 118 patients was considered suitable for exploration of AAA coexistence with CAD. 
Results: Significant coronary stenosis (> 70%) were found in 65.3% of patients. History of cardiac 
revascularization was present in 26.3% of patients, myocardial infarction (MI) in 31.4%, and 39.8% 
had both. In a subgroup analysis, prior history of percutaneous coronary intervention (PCI) (OR = 6.9, 
95% CI 2.6–18.2, p < 0.001) and patients’ age (OR = 1.1, 95% CI 1.0–1.2, p = 0.007) were independ-
ent predictors of significant coronary stenosis. Only 52.0% (40/77) of patients with significant coronary 
stenosis underwent immediate coronary revascularization prior to aneurysm repair: PCI in 32 cases  
(4 drug-eluting stents and 27 bare metal stents), coronary artery bypass graft in 8 cases. Patients undergo-
ing revascularization prior to surgery had longer mean time from coronary imaging to AAA repair (123.6 
vs. 58.1 days, p < 0.001). Patients undergoing coronary artery evaluation prior to AAA repair had shorter 
median hospitalization (7 [2–70] vs. 7 [3–181] days, p = 0.007) and intensive care unit stay (1 [0–9] vs. 
1 [0–70] days, p = 0.014) and also had a lower rate of major adverse cardiovascular events or multiple 
organ failure (0% vs. 3.9%, p = 0.035). A total of 11.0% of patients had coronary artery aneurysms. 
Conclusion: Patients with AAA might benefit from an early coronary artery evaluation strategy.  
(Cardiol J XXXX; XX, X: xx–xx)
Key words: abdominal aortic aneurysm, coronary artery aneurysm, coronary  
arteriography, coronary artery disease
Introduction 
Abdominal aortic aneurysm (AAA) is the lo-
cal pathologic dilation of the abdominal aorta and 
is defined as an aorta size greater than 30 mm or 
a local dilation of abdominal aorta of more than 
50%, as compared to aortic diameter measured 
distally to dilatation [1]. The prevalence of AAA 
in the general population ranges from 1.0% to 
1.3% among females and 3.9–7.2% in males, with 
an upward trend observed in older populations [2, 
3]. Age, male gender, personal history of coronary 
artery disease (CAD), smoking, and hypertension 
are associated with the presence of AAA [4, 5]. 
The open surgical or endovascular aneurysm repair 
(EVAR) methods are the treatments of choice, and 
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no pharmacological management is available to 
effectively limit the disease progression [1, 2, 6, 
7]. AAA and coronary atherosclerosis share com-
mon risk factors [8]. Both the prevalence of CAD 
in patients with AAA and the AAA prevalence in 
CAD patients are significantly higher relative to the 
general population [9]. The frequency of CAD in 
patients with AAA was estimated to be as high as 
65% [10]. Comorbid CAD increases the periopera-
tive risk of death and myocardial ischemia during 
AAA repair, as well as long-term clinical outcomes 
[11, 12]. Intuitively, the preoperative evaluation of 
coronary atherosclerosis, subsequent percutane-
ous coronary intervention (PCI) or coronary artery 
bypass graft (CABG) and myocardial revasculariza-
tion should enhance postoperative prognosis [13, 
14]. The preoperative evaluation of the existence 
of concomitant coronary stenosis appears to be 
reasonable [15, 16]. However, the optimal treat-
ment of patients with both AAA and CAD remains 
controversial. Some studies show no benefits of 
prophylactic coronary interventions before major 
vascular surgery [15, 17], while others recom-
mended this approach for the prevention of perio-
perative complications [18–20]. Current European 
Society of Cardiology and European Society of An-
esthesiology Joint Task Force Guidelines advocate 
similar indications for coronary artery angiography 
(CAG) as in non-surgical settings and recommend 
CAG prior to non-urgent noncardiac surgery in 
patients with proven myocardial ischemia or un-
stable chest pain (Canadian Cardiovascular Society 
class III or IV) despite pharmacological treatment 
(recommendation class I C). These recommenda-
tions also suggest that preoperative CAG might 
be considered in stable patients scheduled for 
carotid endarterectomy (class IIb B), which is an 
intermediate-risk intervention, while disregarding 
the high-risk AAA patients [21]. 
In this study, experience in the management 
of patients with concomitant AAA and CAD is 
presented. The specific aim of current study was 
to re-analyze the coexistence of AAA and CAD 
in a contemporary sample, and finally to evaluate 
the complication rates associated with different 
approaches. One of the leading hypotheses is that 
patients with AAA might benefit from an early coro-
nary artery evaluation strategy and receiving opti-
mal CAD management/therapy prior to AAA repair.
Methods
Two hundred and seventy-one consecutive 
patients were retrospectively reviewed (247 males, 
24 females) who underwent an elective AAA open 
surgery or EVAR from January 2008 through De-
cember 2015 at John Paul II Hospital in Krakow, 
Poland. CAG or multiple-slice coronary computed 
tomography (CT) angiography was available in 144 
patients, out of whom 115 patients had undergone 
coronary imaging within 1 year prior to AAA repair, 
1 patient underwent CAG simultaneously with EVAR 
procedure, and 2 patients were subjected to CAG 
within 2 months postoperatively. Coronary imaging 
in these 118 patients (106 males, 12 females) were 
deemed suitable for exploration of AAA coexistence 
with coronary pathology. Among those patients, 
classical CAG was performed in 89.8% (106/118), in 
the remaining 10.2% of patients (12/118), Electrocar-
diogram (ECG)-gated multi-row contrast-enhanced 
CT was performed using 64- to 256-row scanners.
To analyze factors associated with the pres-
ence of significant coronary stenosis, patients 
with prior CABG were additionally excluded, who 
inherently all had significant stenosis (n = 17). 
Clinical data and postoperative complications were 
recorded for all 271 patients. 
To sum up, three subsets of analyses were 
performed: logistic regression of predictors of coro-
nary stenosis (n = 101), coexistence and manage-
ment of significant stenosis (n = 118), and finally 
an analysis of complication rates in all patients 
(n = 271) dichotomized by the facts of then, current 
preoperative coronary evaluation. 
The AAA repair was performed either using 
open surgery or EVAR technique. Each patient was 
qualified for EVAR or classic repair by a vascular 
team comprising vascular surgeons, angiologists, 
interventional cardiologists, and anesthesiologists. 
The treatment decisions were based on the pro-
cedural guidelines, depending on the anatomy of 
the lesion, required scope of the procedure, perio-
perative risk, and comorbid conditions, including 
contraindications to general anesthesia, as well as 
the overall state of health and prognosis. The con-
ducting physician and vascular team also decided 
whether preoperative coronary artery evaluation 
was necessary. Demographics, past medical his-
tory, information on treatments, and results of 
laboratory and imaging tests of all patients from 
the study group were collected from the patient 
medical records. The study complied with local 
bioethics committee regulations according to the 
Declaration of Helsinki.
Statistical analysis
Data are presented as percentages, mean 
values with corresponding standard deviations or 
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medians and ranges as appropriate. The Shapiro-
Wilk was used test to determine if quantitative data 
were normally distributed. The Levene test was 
relied upon to verify variance homogeneity. The 
Student t-test and Mann-Whitney U test were used 
to statistically compare the two groups, as appropri-
ate. Analysis of variance (ANOVA) was performed 
if a discriminating factor categorized quantitative 
variables into more than two groups and variance 
homogeneity assumption was fulfilled. In post-hoc 
analyses, we relied on the Tukey test of multiple 
comparisons. A multiple logistic regression model 
was built by the inclusion of all univariately sig-
nificant predictors along all available established 
risk factors and subsequent backward elimination 
(a for inclusion and elimination was set at 0.05). 
Additionally, graphs were generated to illustrate 
these analyses. Statistical analyses were conducted 
using STATISTICA v12 (StatSoft Inc., 2014). 
A p-value of less than 0.05 was considered significant.
Results
Patients characteristics
Clinical characteristics of all enrolled patients 
are summarized in Table 1. No death during the 
AAA repair procedure was observed, and only one 
in-hospital death was observed due to massive 
bleeding and cardiac arrest in an urgent patient 
without coronary artery evaluation prior to AAA 
open repair. History of cardiac revascularization 
(PCI or CABG) was present in 26.3% of cases and 
history of MI in 31.4%, while 39.8% of patients 
had both. 
Coronary artery stenosis in AAA patients
In patients who underwent coronary artery 
imaging, significant coronary stenosis (> 70%) 
were found in 65.3% (77/118). The distribution 
of significant stenosis between major coronary 
branches is shown in Figure 1. Overall, the single-
vessel disease was found in 34.7% of patients, 
two-vessel in 11.9%, and three-vessel in 11.0%. In 
7.6% of all cases, there was significant stenosis of 
the left main coronary artery. Almost all patients 
had visible atherosclerotic coronary lesions and 
in only 2.5% (3) of patients had no atherosclerotic 
evidence found in standard CAG. 
Predictors of coronary stenoses  
in AAA patients
The presence of significant coronary lesions in 
multiple logistic regression analysis was assessed 
in a subgroup of patients with coronary artery imag-
ing but without a prior history of CABG (n = 101), 
who inherently all presented with significant le-
sions (n = 17). Factors univariately associated 
with the presence of significant atherosclerosis in-
cluded prior history of PCI (odds ratio [OR] = 6.1, 
95% confidence interval [CI] 2.5–15.2, p < 0.001), 
MI (OR = 2.8, 95% CI 1.1–7.4, p = 0.036), and 
age (OR = 1.1, 95% CI 1.0–1.2, p = 0.017). The 
model (area under the curve [AUC] = 0.78, 95% 
CI 0.7–0.8; R2 Nagelkerka = 0.30) was built by 
additionally adjusting for sex and sum of modifi-
able cardiovascular risk factors (which were uni-
variately insignificant). Independent predictors of 
significant stenosis comprised the only history of 
prior PCI (OR = 6.9, 95% CI 2.6–18.2, p < 0.001) 
and age (OR = 1.1, 95% CI 1.0–1.2, p = 0.007). 
The proportion of patients with significant coronary 
artery stenosis reached 80.9% (38/47), if there was 
a PCI in anamnesis, however, as much as 40.7% 
(22/54) of patients with AAA and no history of PCI 
or the CABG had significant coronary lesions. 
Management of significant stenosis  
in AAA patients
Only 52.0% (40/77) of patients with significant 
coronary stenosis underwent immediate coronary 
revascularization prior to aneurysm repair: ad 
hoc PCI in 32 cases and urgent CABG in 8 cases. 
Patients undergoing revascularization prior to sur-
gery had longer mean time from coronary artery 
imaging to AAA repair, compared with the remain-
ing patients with significant coronary stenosis 
(123.6 vs. 58.1 days, p < 0.001; Fig. 2), although 
there was no difference in mean AAA diameter 
(60.3 vs. 60.3 mm, p = 0.996). ANOVA and the 
Tukey post hoc analyses revealed that PCI with 
drug-eluting stent or drug-eluting balloon (DES 
or DEB), as well as CABG, were interventions 
that significantly postponed AAA repair, as shown 
in Figure 3 [194.0 days; p = 0.02, and 158.3 days, 
p = 0.04, respectively vs. 63.0 days for conserva-
tive therapy; p < 0.001 for the model). Interest-
ingly, out of 32 patients qualified to ad hoc PCI 
revascularization, only four were implanted with 
DES, and one restenosis was treated with DEB, 
while 27 patients (84.4% of PCI patients) were 
implanted with bare metal stents (BMS) due to 
imminent surgery. Nevertheless, complete ana-
tomical revascularization (defined as the absence 
of significant lesions or chronic occlusion that are 
not secured by a bypass) prior to AAA repair was 
achieved in only 52.5% of patients (62/118).  
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Coronary artery evaluation prior  
to AAA and postoperative outcomes
Patients who had undergone coronary artery 
evaluation (and treatment if indicated) prior to 
aneurysm repair had shorter median stay in the in-
tensive care unit and hospitalization time (Table 2). 
They also tended to have lower major adverse 
cardiovascular event (MACE) rate, which reached 
statistical significance after grouping together with 
multiple organ failure (MOF) (Table 2). These bet-
ter outcomes were observed despite the higher 
incidence of cardiovascular risk factors in this 
group, such as impaired lipid or glucose metabo-
lism, history of prior PCI or presence of peripheral 
Table 1. Clinical characteristics of enrolled patients.
Patients who  
underwent AAA  
repair (n = 271) 
Patients who  
underwent AAA repair 
and coronary artery  
imaging (n = 118) 
Patients who underwent 
AAA repair and coronary 
artery imaging without 
prior CABG (n = 101) 
Clinical features
Age [years] 68.9 ± 7.7 68.9 ± 6.6 69.3 ± 6.5 
Male sex 91.1% 89.8% 89.1% 
Hypertension 87.8% 92.4% 92.1% 
Dyslipidemia 74.3% 79.7% 81.2% 
Diabetes or prediabetes* 24.0% 31.4% 29.7% 
Smoking 33.2% 33.9% 34.7% 
COPD 10.0% 8.5% 7.9% 
Atrial fibrillation 11.4% 11.9% 10.9% 
Peripheral atherosclerosis** 48.0% 55.1% 57.4% 
History of MI 31.7% 32.2% 28.7% 
History of PCI 27.7% 41.5% 46.5% 
History of CABG 18.5% 14.4% 0% 
Heart failure 21.0% 23.7% 17.8% 
EVAR 42.8% 32.2% 31.7% 
Symptomatic AAA 26.2% 23.7% 23.8% 
AAA diameter, median 
(range) [mm] 
59.0 (32–91) 58.0 (38–90) 58.0 (38–90) 
Complications
Perioperative MI 0.7% 0.8% 1.0% 
Cardiac arrest 0.4% 0% 0% 
Perioperative stroke 0.4% 0% 0% 
Perioperative TIA 0.7% 0% 0% 
MACE 1.8% 0.8% 1.0% 
MOF 1.5% 0% 0% 
MACE or MOF 2.2% 0.8% 1.0% 
Reoperation need 3.7% 2.5% 3.0% 
Red blood cell transfusion 17.0% 19.5% 18.8% 
Plasma transfusion 8.9% 11.0% 10.9% 
ICU stay median  
(range) [days] 
1 (0–70) 1 (0–9) 1 (0–9) 
In-hospital stay, median 
(range) [days] 
7 (2–181) 7 (2–70) 7 (2–22)
*Prediabetes includes impaired fasting glucose and impaired glucose tolerance; **Peripheral atherosclerosis encompasses significant lesions 
in carotid and lower extremity arteries; AAA — abdominal aortic aneurysm; CABG — coronary artery bypass grafting; COPD — chronic ob-
structive pulmonary disease; EVAR — endovascular aneurysm repair; ICU — intensive care unit; MACE — major adverse cardiovascular event 
(MI or cardiac arrest or stroke or TIA); MI — myocardial infarction; MOF — multiple organ failure; PCI — percutaneous coronary intervention; 
TIA — transient ischemic attack
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atherosclerosis (Table 2). Also, these patients were 
less frequently undergoing EVAR, and yet the need 
for transfusion of red blood cell concentrates and 
plasma were similar (Table 2). Based on the pre-
sent retrospective data, the approximate number 
needed to treat in avoiding one major complication 
through preoperative coronary evaluation is 26.
Coexistence of AAA and other  
vascular pathologies
Abdominal aortic aneurysm were accompa-
nied by common iliac artery aneurysms in 25.4% 
(30/118), and in another 27.1% of patients (32/118), 
non-aneurysmatic iliac ectasia was present. A sig-
nificant proportion of patients (11.0%, 13/118) also 
presented with aneurysmatic lesions in coronary 
arteries, which were equally distributed between 
LAD
27.1%
LCx
39.0%
RCA
43.2%
18.6% 18.6%
15.3%
22.9%
Figure 1. The distribution of significant stenosis (> 70%) 
between major coronary branches (n = 118). LCx — left 
circumflex artery; LAD — left anterior descending ar-
tery; RCA — right coronary artery.
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abdominal aortic aneurysm (AAA) repair for patients 
with significant coronary stenosis who did not have 
coronary intervention (Group 0) and who underwent 
ad hoc revascularization prior to surgery (Group 1) 
(p < 0.001); CI — onfidence interval; SEM — standard 
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Figure 3. Comparison of mean time from coronary artery imaging to abdominal aortic aneurysm (AAA) repair for 
patients with optimal medical therapy (OMT) of coronary artery disease and patients with different types of interven-
tions; BMS — bare metal stent; CABG — coronary artery bypass graft; DEB — drug-eluting balloons; DES — drug-
eluting stents; CI — confidence interval.
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right and left coronary artery trees. According to 
the classification of Markis et al. [22], 1 patient 
was identified with type I aneurysm (0.9%) and 2 
patients with type II aneurysms (1.7%), of whom 
1 had already undergone surgical removal of the 
proximal right coronary artery aneurysm followed 
by its chronic occlusion. Additionally, 5 patients 
with type III and 5 with type IV aneurysms were 
detected (4.2% each). 
Discussion
Among patients undergoing noncardiac sur-
gery, major vascular surgery is associated with 
Table 2. Clinical features and comparisons of patients who had undergone coronary artery imaging 
within 12 months prior to abdominal aortic aneurysm (AAA) repair and remaining subjects undergoing 
elective AAA repair.
Patients who had undergone 
coronary artery imaging 
within 12 months prior  
to AAA repair (n = 115) 
Remaining subjects  
undergoing elective  
AAA repair (n = 156) 
P
Clinical features
Age [years] 69.0 ± 6.7 68.9 ± 8.4 0.907 
Male sex 90.4% 91.7% 0.724 
Hypertension 92.2% 84.6% 0.060 
Dyslipidemia 80.7% 69.5% 0.038 
Diabetes or prediabetes* 31.3% 18.6% 0.015 
Smoking 34.6% 36.9% 0.702 
COPD 8.7% 11.0% 0.538 
Atrial fibrillation 12.3% 11.0% 0.739 
Peripheral atherosclerosis** 56.1% 42.9% 0.031 
History of MI 31.3% 32.1% 0.896 
History of PCI 41.7% 17.4% 0.000 
History of CABG 14.8% 21.3% 0.173 
Heart failure 24.8% 18.8% 0.241 
EVAR 32.2% 51.3% 0.002 
Symptomatic AAA 23.6% 33.1% 0.104 
AAA diameter, median (range) [mm] 58.5 (38–90) 59.0 (32–91) 0.562 
Complications
Perioperative MI 0% 1.3% 0.330 
Cardiac arrest 0% 0.6% 0.576 
Perioperative stroke 0% 0.6% 0.576 
Perioperative TIA 0% 1.3% 0.330 
MACE 0% 3.2% 0.061 
MOF 0% 2.6% 0.108 
MACE or MOF 0% 3.9% 0.035 
Reoperation need 2.6% 4.5% 0.628 
Red blood cell transfusion 20.0% 14.7% 0.254 
Plasma transfusion 11.3% 7.1% 0.223 
In-hospital death 0% 0.6% 0.576 
ICU stay, median (range) [days] 1 (0–9) 1 (0–70) 0.014 
In-hospital stay, median (range) [days] 7 (2–70) 7 (3–181) 0.007 
*Prediabetes includes impaired fasting glucose and impaired glucose tolerance; **Peripheral atherosclerosis encompasses significant lesions 
in carotid and lower extremity arteries; AAA — abdominal aortic aneurysm; CABG — coronary artery bypass grafting; COPD — chronic ob-
structive pulmonary disease; EVAR — endovascular aneurysm repair; ICU — intensive care unit; MACE — major adverse cardiovascular event 
(MI or cardiac arrest or stroke or TIA); MI — myocardial infarction; MOF — multiple organ failure; PCI — percutaneous coronary intervention; 
TIA — transient ischemic attack
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a high risk of perioperative MI. The highest inci-
dence of periprocedural MI is observed in patients 
undergoing open AAA repair (3.7%). Moreover, 
patients with MI had higher overall complication 
rates and mortality, emphasizing the necessity 
of preventing this morbid complication [23]. The 
current study confirms that the prevalence of 
CAD in a contemporary sample of patients with 
AAA is considerably high — two-thirds of patients 
undergoing AAA repair had significant coronary 
stenosis. This is similar to previous reports reach-
ing 65%, despite better risk factor management 
and modern pharmacotherapy available [10, 15, 
24, 25]. Even patients without any prior history 
of cardiac revascularization had significant lesions 
(found in 2 of every 5 subjects), and those already 
after PCI had significant lesions in as much as 4 
in every 5 patients. It is still unclear whether this 
high association between the presence of AAA and 
atherosclerosis is causal or simply due to shared 
risk factors, as well as which risk factors contribute 
most to this phenomenon [8, 26, 27].
Coronary revascularization is an established 
method of reducing cardiovascular events, but 
interestingly, a randomized trial carried out in 
patients undergoing major vascular surgery failed 
to demonstrate the benefits of prophylactic CAD 
treatment for the clinical outcomes in patients 
with angiographically determined coronary artery 
stenosis [17, 28]. Current guidelines indicate that 
there is no known benefit for elective coronary 
revascularization of asymptomatic lesions prior to 
AAA repair [17]. Also, Hosokawa et al. [15] show 
that in patients undergoing AAA open repair and 
coronary artery intervention, the cardiac event-
free rate was comparable with that of other groups, 
although mortality was higher. On the other hand, 
Kordowicz et al. [29] conclude that simultaneous 
open repair of AAA and cardiac surgery is a feasible 
option for patients with CAD. Similar conclusions 
were reached by Sumin et al. [20], where CAG and 
preventive revascularization before AAA surgery 
were associated with less perioperative complica-
tions, MIs, and lower mortality. Moreover, Sun et 
al. [18], after retrospective analysis of 368 Chinese 
patients with AAA, concluded that myocardial 
evaluation and subsequent revascularization before 
AAA surgery could improve the clinical outcome 
in patients with severe CAD.
Because elective open surgical aneurysm 
repair is considered high-risk surgery, when AAA 
and symptomatic CAD are detected, coronary 
artery revascularization (PCI or CABG) should be 
performed before AAA open repair [30]. However, 
the prevalence of asymptomatic, significant CAD 
in patients with AAA was found to be as high as 
61% and, moreover, 31% of these patients fulfilled 
indications for coronary revascularization [31]. 
There is, therefore, a significant group of patients 
with asymptomatic but severe CAD that do not 
undergo coronary artery evaluation and necessary 
revascularization before high-risk AAA surgery. In 
the current study, 65.3% of all patients with AAA 
who underwent coronary evaluation have sig-
nificant coronary stenosis (≥ 70% diameter), with 
40.7% of those were without prior history of PCI 
or CABG. Only 52% of those patients underwent 
immediate coronary revascularization prior to AAA 
repair, and the intervention was associated with 
postponement of surgery or EVAR. Furthermore, 
revascularization was performed using optimal 
techniques (CABG or PCI with DES/DEB) only 
in 32.5% of cases, and BMS was implanted in the 
remaining 67.5% of patients (because of a need 
for an immediate AAA repair). We also found that 
patients who underwent coronary artery evaluation 
(and treatment if indicated) prior to AAA repair had 
shorter median intensive care unit stay and whole 
hospitalization time, as well as lower MACE or 
MOF rate (Table 2). Interestingly, better outcomes 
in patients with coronary imaging were observed 
despite a higher prevalence of cardiovascular risk 
factors in this group, which could be explained 
by the fact that they were probably more care-
fully diagnosed, and pharmacotherapy was better 
optimized, subject to the individual approach of 
the conducting physicians. Furthermore, patients 
with prior coronary imaging were less frequently 
undergoing EVAR, and there was no statistically 
significant difference in the need for red blood 
cell concentrates and plasma transfusion, despite 
probably more frequent current or recent dual an-
tiplatelet therapy (exact pharmacotherapy was not 
recorded in the current study). These observations 
lead us to conclude that coronary artery evaluation 
should be performed in all patients with diagnosed 
AAA at the earliest possible stage. 
The overall incidence of coronary artery an-
eurysm is estimated to be from 0.3% to 5.3% [32]. 
The present study brought significantly increased 
prevalence of the coronary artery aneurysms, that 
was found in 11.0% of all patients. Other authors 
also noted that there is a high incidence (of up to 
17%) of coronary aneurysms in patients with aortic 
aneurysms in both thoracic and abdominal seg-
ments [33]. However, pathophysiological mecha-
nisms behind coronary artery aneurysms remain 
debatable; the phenomenon of their co-occurrence 
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with the AAAs could have several reasonable expla-
nations. First, the most common cause of coronary 
artery aneurysms is CAD, which is also the main 
risk factor for AAA development [34]. Second, 
hereditary connective tissue disorders and muta-
tions in matrix metalloproteinases genes can result 
in both aortic and coronary aneurysms [32, 35]. 
Moreover, the coronary artery aneurysms might 
have an iatrogenic origin and occur as a complica-
tion after balloon angioplasty or stent implantation, 
interventions that were frequent in the present 
study population [32]. Finally, chronic inflamma-
tion might be associated with the coexistence of 
the AAAs, CAD, and coronary artery aneurysms 
[36]. Patients with aneurysmal coronary disease 
are usually asymptomatic and, even in the absence 
of obstructive CAD, have an increased risk of MI 
and mortality rate similar to patients suffering from 
three-vessel obstructive CAD [37, 38]. In this light, 
patients with AAA might additionally benefit from 
early coronary artery evaluation [39].
Limitations of the study
The current study is not without limitations. 
This study was a retrospective, cross-sectional, 
single-center study, which might contribute to 
selection bias. However, results were comparable 
to other reports. A relatively large sample size 
was presented for the field, but were too small 
to reliably assess any rare observations [15, 
24, 25]. The qualification criteria for coronary 
artery evaluation were subject to the individual 
practice of the conducting physician and not a 
randomization process. Hence, it was only pos-
sible to retrospectively approximate, rather than 
directly compare, the differences in outcomes 
between patients undergoing preoperative coro-
nary evaluation and those entering the procedure 
without such preprocedural assessment. The 
identified factors influencing the decision to evalu-
ate coronary arteries before surgery included: 
history of hypercholesterolemia, diabetes, prior 
PCI, and qualification for classical AAA open 
repair, as indicated in Table 2. Moreover, due to 
the retrospective nature of the study, complica-
tions were derived from medical records and not 
proactively assessed throughout hospitalization, 
for instance, by routine monitoring of cardiac 
biomarkers [40]. Due to the structure of the 
database, it was not possible to identify patients 
that were scheduled for aneurysm repair and died 
before hospital admission. This is a major limita-
tion. However, the probability of such a scenario 
is low, because all patients were scheduled and 
managed based on an individualized risk-benefit 
approach, and patients with a high risk of rupture 
were treated urgently. Moreover, coronary imag-
ing performed outside of the center might have 
been missed and was not indicated in the medical 
history. However, this seems unlikely. Patients 
that had undergone coronary imaging more than 
1 year prior to AAA repair (n = 26) from the 
analysis of coexistence were also arbitrary ex-
cluded. On the other hand, only relevant, current 
CAG were analyzed, which is a major advantage 
of this study, and allowed a demonstration of the 
importance of preoperative evaluation of CAD.
Conclusions
In conclusion, major findings from the current 
study are: (1) despite advancements in risk factor 
management, still 2 of every 3 patients undergo-
ing coronary artery evaluation prior to AAA repair 
have significant coronary lesions; (2) prior history 
of PCI and patient age are independent predictors 
of significant coronary stenoses; (3) patients un-
dergoing “last-minute” coronary imaging receive 
suboptimal, conservative therapy or PCI with 
BMS; (4) nevertheless, patients subjected to pre-
operative coronary evaluation and treatment had a 
lower incidence of composite end-point comprising 
MACE and MOF; and (5) patients with AAA have 
a higher probability of the presence of coronary 
artery aneurysms. It can be concluded that patients 
with AAA might benefit from an early coronary 
artery evaluation strategy.
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